newsfilter
← Latest News
GlobeNewswire·

Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executiv